Cite
APA Citation
Bradshaw, D., Gilleece, Y., Verma, S., Abramowicz, I., Bremner, S., & Perry, N. (2020). protocol for a phase IV, open-label feasibility study investigating non-invasive markers of hepatic fibrosis in people living with HIV-1 and non-alcoholic fatty liver disease randomised to receiving optimised background therapy (OBT) plus maraviroc or OBT alone. BMJ open, 10(7), . http://access.bl.uk/ark:/81055/vdc_100137792584.0x000006